| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | abnormal pulmonary circulation | 2.12e-06 | 69 | 121 | 7 | MP:0002295 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | DOC2A HSPG2 PDE4A TMEM8B POLE CYB561D2 CHD8 EDC4 FBXL19 RALGAPA2 MAST2 TAOK2 SLC8B1 RPAP1 ZBED4 KLHL21 HPS6 PKD1 USP40 LRP4 ZNRF1 FGFR2 ATG9A WDR24 | 5.00e-10 | 1105 | 164 | 24 | 35748872 |
| Pubmed | CHST5 IZUMO4 C6orf89 DHRS13 CDH23 PGLYRP2 TLR9 CDCP1 TAOK2 QSOX1 NTNG2 LCTL CCNL1 ITPRIP WFDC5 CHPF2 ADGRF3 TMEM231 | 1.06e-06 | 985 | 164 | 18 | 12975309 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | SLC5A7 CDH23 RNASEK IDE EDC4 MAST2 CERT1 PRDX6 RETREG3 AMZ2 PITPNM1 EFNA1 DENND1B KLHL21 SLC5A6 RNASEH2C OGFOD1 PRMT7 PLXNB3 | 6.95e-06 | 1242 | 164 | 19 | 30973865 |
| Pubmed | TRIM46 CCNL2 ASH1L CHD8 FAM117B DELE1 MAST2 TENT5B AMZ2 TAOK2 MYG1 TCAIM PKD1 TENM1 FGFR2 B4GALNT3 C6orf141 CFAP46 | 1.89e-05 | 1215 | 164 | 18 | 15146197 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 21211561 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 21867693 | ||
| Pubmed | VARS2 V552V variant as prognostic marker in patients with early breast cancer. | 2.21e-05 | 2 | 164 | 2 | 20503108 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 17360538 | ||
| Pubmed | Recessive mutation in a standard recombinant-inbred line of mice affects seminal vesicle shape. | 2.21e-05 | 2 | 164 | 2 | 3181757 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 22540041 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 24743707 | ||
| Pubmed | The CD318/CD6 axis limits type 1 diabetes islet autoantigen-specific human T cell activation. | 2.21e-05 | 2 | 164 | 2 | 38642507 | |
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 22862946 | ||
| Pubmed | 2.21e-05 | 2 | 164 | 2 | 28760953 | ||
| Pubmed | A new murine lymphocyte alloantigen, Ly-21.2, mapping to the seventh chromosome. | 2.21e-05 | 2 | 164 | 2 | 6802749 | |
| Pubmed | Precise mapping of the gene for Ly-21.2 on the 7th chromosome. | 6.61e-05 | 3 | 164 | 2 | 7161508 | |
| Pubmed | CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. | 6.61e-05 | 3 | 164 | 2 | 17261272 | |
| Pubmed | 6.61e-05 | 3 | 164 | 2 | 8175886 | ||
| Pubmed | 6.61e-05 | 3 | 164 | 2 | 21865467 | ||
| Pubmed | Characterization of cyclin L1 as an immobile component of the splicing factor compartment. | 6.61e-05 | 3 | 164 | 2 | 17494991 | |
| Pubmed | 6.61e-05 | 3 | 164 | 2 | 18216018 | ||
| Pubmed | Secretin deficiency causes impairment in survival of neural progenitor cells in mice. | 6.61e-05 | 3 | 164 | 2 | 21159798 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | SPNS1 MBOAT7 TMEM8B ASH1L CH25H RNASEK QSOX1 NTNG2 SLC5A6 MRAP PKD1 TMEM231 | 1.26e-04 | 697 | 164 | 12 | 28298427 |
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 1680807 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 24436071 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 30661429 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 24459426 | ||
| Pubmed | Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. | 1.32e-04 | 4 | 164 | 2 | 2217177 | |
| Pubmed | Impact of viral and host DNA methylations on HPV16-related cervical cancer pathogenesis. | 1.32e-04 | 4 | 164 | 2 | 28459195 | |
| Pubmed | FGFR2, FGF8, FGF10 and BMP7 as candidate genes for hypospadias. | 1.32e-04 | 4 | 164 | 2 | 17264867 | |
| Pubmed | The mouse frizzy mutation (fr) maps between D7Csu5 and D7Mit165. | 1.32e-04 | 4 | 164 | 2 | 18177347 | |
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 273256 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 31971654 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 27265029 | ||
| Pubmed | Delipidation of mammalian Atg8-family proteins by each of the four ATG4 proteases. | 1.32e-04 | 4 | 164 | 2 | 29458288 | |
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 9348221 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 24072698 | ||
| Pubmed | 1.32e-04 | 4 | 164 | 2 | 19844242 | ||
| Pubmed | 1.34e-04 | 164 | 164 | 6 | 32409323 | ||
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 11683997 | ||
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 23509775 | ||
| Pubmed | Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. | 2.19e-04 | 5 | 164 | 2 | 11437450 | |
| Pubmed | Genetic variations in the fine structure and ontogeny of mouse melanin granules. | 2.19e-04 | 5 | 164 | 2 | 5902512 | |
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 21177865 | ||
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 12666202 | ||
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 17959718 | ||
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 9857059 | ||
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 18890162 | ||
| Pubmed | Intracellular MMP3 Promotes HSP Gene Expression in Collaboration With Chromobox Proteins. | 2.19e-04 | 5 | 164 | 2 | 27206651 | |
| Pubmed | 2.19e-04 | 5 | 164 | 2 | 17516030 | ||
| Pubmed | 2.30e-04 | 257 | 164 | 7 | 30945288 | ||
| Pubmed | 2.64e-04 | 186 | 164 | 6 | 20673868 | ||
| Pubmed | 2.64e-04 | 186 | 164 | 6 | 20452482 | ||
| Pubmed | CCNL2 MAP1A ASH1L CHD8 RALGAPA2 MAST2 SLC4A1 FAM120A EML5 ZFHX4 KLHL21 LRP4 CHPF2 TIGD5 ANAPC4 | 2.76e-04 | 1116 | 164 | 15 | 31753913 | |
| Pubmed | SPNS1 HJURP RNASEK MAST2 TAOK2 BMP7 FAM120A ZFHX4 CLEC11A RNASEH2C PKD1 ZNRF1 FGFR2 PRMT7 | 3.14e-04 | 1006 | 164 | 14 | 15226823 | |
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 3.27e-04 | 6 | 164 | 2 | 26025922 | |
| Pubmed | 3.27e-04 | 6 | 164 | 2 | 26854227 | ||
| Pubmed | 3.27e-04 | 6 | 164 | 2 | 17181997 | ||
| Pubmed | 3.27e-04 | 6 | 164 | 2 | 28330582 | ||
| Pubmed | 3.27e-04 | 6 | 164 | 2 | 11953439 | ||
| Pubmed | 3.27e-04 | 6 | 164 | 2 | 25219500 | ||
| Pubmed | 3.27e-04 | 6 | 164 | 2 | 12697906 | ||
| Pubmed | 3.27e-04 | 6 | 164 | 2 | 30590377 | ||
| Pubmed | Matrix metalloproteinase activity in pediatric acute lung injury. | 3.27e-04 | 6 | 164 | 2 | 19159011 | |
| Pubmed | ATG4 family proteins drive phagophore growth independently of the LC3/GABARAP lipidation system. | 3.27e-04 | 6 | 164 | 2 | 33773106 | |
| Pubmed | Use of two-dimensional electrophoresis to identify and map new mouse genes. | 3.27e-04 | 6 | 164 | 2 | 447069 | |
| Pubmed | Cell-surface proteomics identifies lineage-specific markers of embryo-derived stem cells. | 3.44e-04 | 29 | 164 | 3 | 22424930 | |
| Pubmed | 4.57e-04 | 7 | 164 | 2 | 20058854 | ||
| Pubmed | 4.57e-04 | 7 | 164 | 2 | 23665963 | ||
| Pubmed | 4.57e-04 | 7 | 164 | 2 | 25368159 | ||
| Pubmed | 4.57e-04 | 7 | 164 | 2 | 25490467 | ||
| Pubmed | The G protein-coupled receptor repertoires of human and mouse. | 5.44e-04 | 79 | 164 | 4 | 12679517 | |
| Pubmed | 6.03e-04 | 35 | 164 | 3 | 19844255 | ||
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 6.07e-04 | 8 | 164 | 2 | 19683999 | |
| Pubmed | Molecular mapping of the tubby (tub) mutation on mouse chromosome 7. | 6.07e-04 | 8 | 164 | 2 | 8833147 | |
| Pubmed | Roles of Mis18α in epigenetic regulation of centromeric chromatin and CENP-A loading. | 6.07e-04 | 8 | 164 | 2 | 22516971 | |
| Pubmed | Association and mutation analyses of 16p11.2 autism candidate genes. | 6.07e-04 | 8 | 164 | 2 | 19242545 | |
| Pubmed | 6.07e-04 | 8 | 164 | 2 | 18484607 | ||
| Pubmed | 6.07e-04 | 8 | 164 | 2 | 16545802 | ||
| Pubmed | 6.07e-04 | 8 | 164 | 2 | 8674412 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MBTPS1 LMF1 SRD5A3 TMEM8B FAM53A ASH1L FAM117B IDE CERT1 PRDX6 EFNA1 SLC8B1 DENND1B FAM120A TESMIN USP40 MED27 | 7.03e-04 | 1489 | 164 | 17 | 28611215 |
| Pubmed | The Effects of Genotype and Cell Environment on Melanoblast Differentiation in the House Mouse. | 7.79e-04 | 9 | 164 | 2 | 17247639 | |
| Pubmed | 7.79e-04 | 9 | 164 | 2 | 14623875 | ||
| Pubmed | The fine structure of melanogenesis in coat color mutants of the mouse. | 7.79e-04 | 9 | 164 | 2 | 4634048 | |
| Pubmed | 7.79e-04 | 9 | 164 | 2 | 9108368 | ||
| Pubmed | 8.31e-04 | 39 | 164 | 3 | 33580754 | ||
| Pubmed | 8.33e-04 | 415 | 164 | 8 | 16385451 | ||
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 8.47e-04 | 232 | 164 | 6 | 25515538 | |
| Pubmed | A Role for Mitochondrial Translation in Promotion of Viability in K-Ras Mutant Cells. | 8.86e-04 | 419 | 164 | 8 | 28700943 | |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 9.70e-04 | 10 | 164 | 2 | 24618850 | |
| Pubmed | 9.70e-04 | 10 | 164 | 2 | 17048991 | ||
| Pubmed | 9.70e-04 | 10 | 164 | 2 | 24239741 | ||
| Pubmed | Localization of non-Mhc collagen-induced arthritis susceptibility loci in DBA/1j mice. | 9.70e-04 | 10 | 164 | 2 | 10051620 | |
| Pubmed | 9.70e-04 | 10 | 164 | 2 | 20700443 | ||
| Pubmed | 9.70e-04 | 10 | 164 | 2 | 15670850 | ||
| Pubmed | 9.70e-04 | 10 | 164 | 2 | 28287329 | ||
| Pubmed | Strain background effects and genetic modifiers of hearing in mice. | 1.18e-03 | 11 | 164 | 2 | 16579977 | |
| Pubmed | 1.18e-03 | 11 | 164 | 2 | 24349473 | ||
| Pubmed | Progression of calvarial bone development requires Foxc1 regulation of Msx2 and Alx4. | 1.18e-03 | 11 | 164 | 2 | 14512019 | |
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 1.18e-03 | 11 | 164 | 2 | 17023412 | |
| Cytoband | 16p11.2 | 4.86e-07 | 191 | 164 | 8 | 16p11.2 | |
| Cytoband | 16q23.1 | 5.22e-06 | 32 | 164 | 4 | 16q23.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 7.90e-06 | 278 | 164 | 8 | chr16p11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q23 | 6.37e-05 | 116 | 164 | 5 | chr16q23 | |
| Cytoband | 12q13-q14 | 1.88e-04 | 6 | 164 | 2 | 12q13-q14 | |
| GeneFamily | Glucagon receptor family | 4.30e-04 | 6 | 98 | 2 | 269 | |
| GeneFamily | Autophagy related | 7.49e-04 | 33 | 98 | 3 | 1022 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.65e-07 | 191 | 164 | 8 | 989bf108c7f2c78dd7f14481570f1819673a5469 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.65e-07 | 191 | 164 | 8 | 3e7fbe4af2c23b3b964becde843d2f088ad41c23 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.65e-07 | 191 | 164 | 8 | bc2f3c4e71e3a55fe76ea03f45746329a8fc81da | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.88e-07 | 192 | 164 | 8 | d9ff2293358c8b031ba212021012e058014ff472 | |
| ToppCell | Severe_COVID-19-Myeloid-pDC|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 5.88e-07 | 192 | 164 | 8 | f79424c643a375dfe4579eff7ac1ba191e28a283 | |
| ToppCell | BAL-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.88e-07 | 192 | 164 | 8 | 2e8611d65090e39f1a6e74c972288e7b68376d15 | |
| ToppCell | BAL-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.88e-07 | 192 | 164 | 8 | 43569726df281eebe57499e0993b9fd9d36118c2 | |
| ToppCell | distal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.87e-07 | 196 | 164 | 8 | 6028b790abba9bad1d5373bab13eb24855988f48 | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.14e-07 | 197 | 164 | 8 | 3a5908deb5c5a2bf06019a102fb1652233cf2a2a | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-06 | 153 | 164 | 7 | 3b1b0cc8e9dd2b1484649789330713282ee44414 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 171 | 164 | 7 | f3bf5805823d5733b58742172e7668725ce82931 | |
| ToppCell | 368C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-06 | 171 | 164 | 7 | 714a0b0d0c9886fef64170cf53eb64f0d8a47280 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-Late_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.15e-06 | 182 | 164 | 7 | f8257c884393f168f605d371e0840cfca8d3657e | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.73e-06 | 185 | 164 | 7 | f4588468e8654363f48adbe427dff10f16f1c7fe | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.73e-06 | 185 | 164 | 7 | 3cb816fc9541c04b4436e21d984216cfbbacff98 | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.73e-06 | 185 | 164 | 7 | c2e70405969616c28fb6379ee318e17bbcef7b49 | |
| ToppCell | Mild-Lymphoid-pDC|Mild / Condition, Lineage, Cell class and cell subclass | 5.93e-06 | 186 | 164 | 7 | 7fa82972c726025d6402e5eb7bf0db3b699eba4c | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.93e-06 | 186 | 164 | 7 | b031f4e6867b6200b85f43276a34749bf5f4603f | |
| ToppCell | BAL-Mild-Myeloid-pDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.93e-06 | 186 | 164 | 7 | d2fbf53aac905c9896272ec5c2db28ee1a60f4be | |
| ToppCell | Mild-Lymphoid-pDC-|Mild / Condition, Lineage, Cell class and cell subclass | 5.93e-06 | 186 | 164 | 7 | 1d05e73ae2ec0cc27f79e4fa40d6b21790059f80 | |
| ToppCell | BAL-Mild-Myeloid-pDC-pDC-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.93e-06 | 186 | 164 | 7 | 79aedd5aed72509a4925e9f6cb43bc0c798c86f5 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Cbln1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.05e-06 | 70 | 164 | 5 | 8d6bdf2e773e894a0db39fdff1fafc2474e03fcf | |
| ToppCell | Mild_COVID-19-Myeloid-pDC|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.15e-06 | 187 | 164 | 7 | 99c3c4a7b9179dce7982dc6516d561c952abc80e | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-pDC|bone_marrow / Manually curated celltypes from each tissue | 6.82e-06 | 190 | 164 | 7 | dde0e34f6a06cdbbb65c86472360c09f0279a572 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.82e-06 | 190 | 164 | 7 | ae97df1b06bcd46c05759b53c35dc8fea97f4ac1 | |
| ToppCell | COVID-19-Lymphoid-pDC|COVID-19 / Condition, Lineage and Cell class | 7.06e-06 | 191 | 164 | 7 | 25343b11d42128ad16659e5519cd1673266cc505 | |
| ToppCell | LPS_only-Endothelial-Epi-like|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-06 | 126 | 164 | 6 | 4c598f7bae09aca7a4ecce63dfd6890b26468c73 | |
| ToppCell | LPS_only-Endothelial-Epi-like-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-06 | 126 | 164 | 6 | e065304f480a5e38532b66508b0ee87cc48bba9b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.81e-06 | 194 | 164 | 7 | 5250736b608001fb73aa74dee8cb8465a1d2f372 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.35e-06 | 196 | 164 | 7 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD4-T_reg|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-06 | 196 | 164 | 7 | 6362fb0b5dc923f19a76b605d7289a16f89220e3 | |
| ToppCell | LPS-antiTNF-Lymphocytic_NKT-T_cells-iNKT-MAIT|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-05 | 140 | 164 | 6 | a8f3b01d03ee0bf0e752327a98d6b9035930c2b0 | |
| ToppCell | Control-Lymphocytic_NKT-T_cells-iNKT-MAIT|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-05 | 151 | 164 | 6 | 7e5e35ce601ca3d3722063566e89664909171b8d | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic-pDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.85e-05 | 160 | 164 | 6 | 61f4cb4eb4313d8318aadbb99595a6cb7fd919f7 | |
| ToppCell | COVID_non-vent-Lymphocytic-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.85e-05 | 160 | 164 | 6 | 34b4f710cfcb6ec370b8b074f3cbfe272f392cec | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 3.06e-05 | 162 | 164 | 6 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | Influenza_Severe-pDC|World / Disease group and Cell class | 3.51e-05 | 166 | 164 | 6 | bd25ce4c03c3d6cd9d986b9be1d355da52f0f2d7 | |
| ToppCell | Influenza_Severe-pDC|Influenza_Severe / Disease group and Cell class | 3.51e-05 | 166 | 164 | 6 | b43a5cd4d28118cf6e56a435deb8ea9435608a90 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-05 | 166 | 164 | 6 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 3.75e-05 | 168 | 164 | 6 | 90f713dae3fcbd6ca801a019e3861c263ff3366b | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 3.75e-05 | 168 | 164 | 6 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-pDC|blood / Manually curated celltypes from each tissue | 4.01e-05 | 170 | 164 | 6 | 59cb1262ff319349d42b11afbec2a9035b7b79f2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-05 | 173 | 164 | 6 | ab6d3507301038f944ad59ccd848b5e6eeb76d04 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 4.56e-05 | 174 | 164 | 6 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_dendritic-plasmacytoid_dendritic_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.71e-05 | 175 | 164 | 6 | 97fe431f224b592b3076632d101e19136c138dcc | |
| ToppCell | Control-Lymphoid-pDC|Control / Condition, Lineage and Cell class | 4.86e-05 | 176 | 164 | 6 | 5de16ff65476bde8b23322a44e11412e14f1bafe | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.86e-05 | 176 | 164 | 6 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | renal_papilla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 5.51e-05 | 180 | 164 | 6 | 49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4 | |
| ToppCell | Severe-Lymphoid-pDC|Severe / Condition, Lineage, Cell class and cell subclass | 5.68e-05 | 181 | 164 | 6 | 2caecb7c5dcdad46fd02b4ffb73cb613ce835187 | |
| ToppCell | 3'_v3-Lung-Myeloid_Dendritic-pDC|Lung / Manually curated celltypes from each tissue | 5.68e-05 | 181 | 164 | 6 | 3d7f089fb434fbc989f1fa159e22133ae00b2487 | |
| ToppCell | Severe-Lymphoid-pDC-|Severe / Condition, Lineage, Cell class and cell subclass | 5.68e-05 | 181 | 164 | 6 | 277ce4c49121da0990a5933b19d2c6af9bbe253e | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.86e-05 | 182 | 164 | 6 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.04e-05 | 183 | 164 | 6 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 6.41e-05 | 185 | 164 | 6 | 492529121cb9e88bd3c0db6b54af3cd2979572bc | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 186 | 164 | 6 | 31df1eafa3010bc1be6fc4d4689f1393d69b6b13 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 186 | 164 | 6 | eaa431ccd4cdd36fe06a44987603ec9979025aa8 | |
| ToppCell | PBMC-Severe-Myeloid-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.61e-05 | 186 | 164 | 6 | b95be984e308d4f9061274a35995ec558d434e74 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.61e-05 | 186 | 164 | 6 | 8f7949740286f64e034d1eb533ebc2c6f71ae966 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.61e-05 | 186 | 164 | 6 | 95c7318e521fb6aa02e244b1e81e6b2a62107756 | |
| ToppCell | PBMC-Severe-Myeloid-pDC-pDC|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.61e-05 | 186 | 164 | 6 | b70cd94c651b56dcf2e55554533a5f1130845390 | |
| ToppCell | COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease group, lineage and cell class | 6.61e-05 | 186 | 164 | 6 | 3db5ed69d49e5d79f990aca0295ddce4c297a05c | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-05 | 188 | 164 | 6 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.01e-05 | 188 | 164 | 6 | 9655a4c47b644a870017d349b99063e17dbae572 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.01e-05 | 188 | 164 | 6 | 505b6b4277d7dea87aee27191d0acca67928b8e6 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.01e-05 | 188 | 164 | 6 | 1f820cb19eb0e15f0eb69d07e457072bbdad8ecb | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.22e-05 | 189 | 164 | 6 | 784ace2be87f2ecb19490f4974f63a559516e0eb | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.22e-05 | 189 | 164 | 6 | 42ab4cc5fbf8580841f31889446fe4499df1a464 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.22e-05 | 189 | 164 | 6 | 37ecbd73408d462b47d7e5611f203143e08a2689 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.43e-05 | 190 | 164 | 6 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-05 | 190 | 164 | 6 | 2de8e4cfeee350a9a76af749d6ce58d948c129b8 | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 7.43e-05 | 190 | 164 | 6 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.43e-05 | 190 | 164 | 6 | 07f21386ea6eb23416a537d2250e3042efe93fb0 | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class | 7.43e-05 | 190 | 164 | 6 | c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.43e-05 | 190 | 164 | 6 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 7.65e-05 | 191 | 164 | 6 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | COVID-19_Moderate-pDC|COVID-19_Moderate / disease group, cell group and cell class | 7.65e-05 | 191 | 164 | 6 | 9d0ffa65c547e20b4076fd97776d7738cbd453ec | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-pDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 7.65e-05 | 191 | 164 | 6 | faf4de97003a938a243b0101456913c2b0e1804f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 191 | 164 | 6 | 2b056cbe2e82e056e1f798974999378460eb1d16 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 191 | 164 | 6 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-05 | 191 | 164 | 6 | a90c8ab2077e52bbc998457c85a1b9867f9c8c93 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.87e-05 | 192 | 164 | 6 | be5e246b2350398b985767b2fbede17a8dd8cc44 | |
| ToppCell | VE-pDC-|VE / Condition, Cell_class and T cell subcluster | 8.10e-05 | 193 | 164 | 6 | 583724de588fcde3aeda056138c522dc0225a387 | |
| ToppCell | VE-pDC|VE / Condition, Cell_class and T cell subcluster | 8.10e-05 | 193 | 164 | 6 | bb759dc9ef0ec41d655002f59021d62d62d44289 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-05 | 194 | 164 | 6 | c5e77650d7abee339ec38fa78a622bb124db3fa5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.33e-05 | 194 | 164 | 6 | 3f9e4a8e5699bc379e8a0d337e0daef09632e71c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-mesenchymal_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 8.56e-05 | 121 | 164 | 5 | 176de42c088988fe1a7838f96add26ee8a30e543 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.57e-05 | 195 | 164 | 6 | df644b4c3ddccd34614ece5a2378000e6bc0fa10 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Dendritic_cell-DC_plasmacytoid|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.57e-05 | 195 | 164 | 6 | fbc324c3435f32b9ca269d83333faecfe940d7fe | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.82e-05 | 196 | 164 | 6 | 170629b9ae82e9a911b93e8739dcd38176fbecb4 | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 8.82e-05 | 196 | 164 | 6 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.82e-05 | 196 | 164 | 6 | 1bcae4e0a244af822e2b12b2026a2771316f107d | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-pDC|Influenza_Severe / Disease, condition lineage and cell class | 9.06e-05 | 197 | 164 | 6 | e8e6f71e6dc8a695e4321a18543c1df63dd62f3e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.06e-05 | 197 | 164 | 6 | 467e7cbf511d3bcc701923603032aaf0bba2736d | |
| ToppCell | distal-Hematologic-Plasmacytoid_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.32e-05 | 198 | 164 | 6 | bb03744d8372405c278a0781e2f513bed00cf2b3 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 9.32e-05 | 198 | 164 | 6 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | distal-2-Hematologic-Plasmacytoid_Dendritic|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.58e-05 | 199 | 164 | 6 | 78796b05d28b35e7361b6271d4a3858faa39c45c | |
| ToppCell | Transverse-T_cell-Tfh|T_cell / Region, Cell class and subclass | 9.58e-05 | 199 | 164 | 6 | 33ffea12b8228e0b5bd8942531c3b21d24224725 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Airway|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.61e-05 | 124 | 164 | 5 | d88bce8a4f023d5b617b2e8e372a94bd1248d20d | |
| ToppCell | Macroglial|World / cells hierarchy compared to all cells using T-Statistic | 9.85e-05 | 200 | 164 | 6 | e6935ad49216d2500c15c05cbc2b89402c65e838 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 9.85e-05 | 200 | 164 | 6 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| Drug | U0125; Up 200; 1uM; PC3; HG-U133A | DPP4 MBTPS1 IFFO1 JMJD4 DELE1 CRYAB PHKG2 CLEC11A CHPF2 PRMT7 | 1.40e-06 | 196 | 161 | 10 | 663_UP |
| Disease | magnesium measurement | 4.62e-04 | 66 | 160 | 4 | EFO_0004845 | |
| Disease | stromal cell-derived factor 1 measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0020756 | |
| Disease | Intellectual Disability | 7.81e-04 | 447 | 160 | 9 | C3714756 | |
| Disease | viral load | 8.95e-04 | 136 | 160 | 5 | EFO_0010125 | |
| Disease | Odontome | 1.28e-03 | 10 | 160 | 2 | C0524730 | |
| Disease | 3-methyl-2-oxobutyrate measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0021020 | |
| Disease | Tooth Abnormalities | 1.28e-03 | 10 | 160 | 2 | C0040427 | |
| Disease | Colorectal Carcinoma | MKRN3 POLE TLR9 GDAP1L1 RPAP1 ABCA6 TOMM40L TENM1 MMP11 ANAPC4 GABPB1 | 1.62e-03 | 702 | 160 | 11 | C0009402 |
| Disease | Craniofacial Abnormalities | 1.65e-03 | 156 | 160 | 5 | C0376634 | |
| Disease | small vessel stroke | 1.88e-03 | 96 | 160 | 4 | EFO_1001504 | |
| Disease | intercellular adhesion molecule 5 measurement | 2.19e-03 | 13 | 160 | 2 | EFO_0008164 | |
| Disease | calcium measurement | TRIM46 TRPM6 MAP1A CHD8 TMEM121 SLC4A1 ABCA6 USP40 MIGA1 TMEM131 | 2.34e-03 | 628 | 160 | 10 | EFO_0004838 |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.43e-03 | 103 | 160 | 4 | EFO_0008595, EFO_0020944 | |
| Disease | atrial fibrillation (is_implicated_in) | 2.55e-03 | 14 | 160 | 2 | DOID:0060224 (is_implicated_in) | |
| Disease | beta-amyloid 1-42 measurement, cerebrospinal fluid biomarker measurement | 2.55e-03 | 14 | 160 | 2 | EFO_0004670, EFO_0006794 | |
| Disease | blood phosphate measurement | 2.65e-03 | 174 | 160 | 5 | EFO_0010972 | |
| Disease | Schizophrenia | PDE4A IDE PTGS1 PRDX6 PITPNM1 TYR NTNG2 EML5 CACNG5 FGFR2 MMP3 DNMT3B | 3.25e-03 | 883 | 160 | 12 | C0036341 |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 3.34e-03 | 16 | 160 | 2 | C0751885 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 3.69e-03 | 57 | 160 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | Benign neoplasm of stomach | 3.77e-03 | 17 | 160 | 2 | C0153943 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 3.77e-03 | 17 | 160 | 2 | C0751883 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 3.77e-03 | 17 | 160 | 2 | C0496905 | |
| Disease | glycochenodeoxycholate measurement | 3.77e-03 | 17 | 160 | 2 | EFO_0010490 | |
| Disease | Carcinoma in situ of stomach | 3.77e-03 | 17 | 160 | 2 | C0154060 | |
| Disease | intelligence, self reported educational attainment | 3.84e-03 | 117 | 160 | 4 | EFO_0004337, EFO_0004784 | |
| Disease | Polydactyly | 3.84e-03 | 117 | 160 | 4 | C0152427 | |
| Disease | Malignant neoplasm of endometrium | 4.22e-03 | 18 | 160 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 4.22e-03 | 18 | 160 | 2 | C0346191 | |
| Disease | serum gamma-glutamyl transferase measurement | TRIM46 CUX2 ZBTB7C MAP1A FAM53A ASH1L FBXL19 NTNG2 EFNA1 PKD1 FGFR2 DNMT3B | 4.28e-03 | 914 | 160 | 12 | EFO_0004532 |
| Disease | gout | 4.40e-03 | 196 | 160 | 5 | EFO_0004274 | |
| Disease | Congenital Myasthenic Syndromes, Presynaptic | 4.70e-03 | 19 | 160 | 2 | C0751884 | |
| Disease | squamous cell carcinoma (is_marker_for) | 4.70e-03 | 19 | 160 | 2 | DOID:1749 (is_marker_for) | |
| Disease | CCL2 measurement | 4.99e-03 | 126 | 160 | 4 | EFO_0004749 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGRLWHTSTVFFHPP | 131 | Q9BYV1 | |
| EATNLSWFLRHPGSP | 261 | Q8IZF5 | |
| WVHREPSESSPLALG | 1556 | Q9NR48 | |
| HLFWPPGSALTARLR | 1736 | Q9HCK8 | |
| DPLNWFGILVPHSLR | 121 | Q96NT0 | |
| LHRLASFHRVWSFPP | 46 | Q9UJX5 | |
| GRSWSVPVIRHLFAP | 831 | Q9UBC3 | |
| RGWVIHPLGLRSEFP | 646 | P02730 | |
| PVPWLSEFRGRANLH | 111 | Q6L9W6 | |
| LHLPWFHPRNVSGFS | 196 | Q9H5V8 | |
| DRATGRPWLPLHTLS | 6 | Q6V0I7 | |
| RIESSPFPLSHIGLW | 996 | Q8N139 | |
| PTFWILFLHLSGDRS | 2166 | Q8IYW2 | |
| AVRAAPHSGPLVSWR | 11 | Q9Y2Z9 | |
| DLFGPITLHSPSDWI | 46 | Q86W34 | |
| LWPSSPASLQRGLHR | 91 | Q9ULJ7 | |
| AAAPVGRFTAHWRVP | 121 | P16066 | |
| LPTRPHWFLLFGTTE | 261 | Q9UK58 | |
| FDPSGQPRRDLHTSW | 121 | O14529 | |
| LRAAAPHSFVALWAP | 6 | P18075 | |
| PHSFVALWAPLFLLR | 11 | P18075 | |
| PRVWTFLAHDRDSGP | 1761 | Q9H251 | |
| ISWFGDSPLALFGLH | 201 | Q96DT6 | |
| ALAHSLGRWLVYPGS | 101 | Q9H3Z7 | |
| LAAGSDHPLPRAAWL | 416 | Q6PCT2 | |
| AAAWGPELPSHRTVL | 96 | Q8NCD3 | |
| LAHGTPPLTFQWSRV | 3321 | P98160 | |
| SEPHFRGFPCSLWVL | 396 | O00391 | |
| PPSFLRAPSWFDTGL | 51 | P02511 | |
| GTPLNHFRRIIWCPF | 226 | Q6P2E9 | |
| RFHPELWCSGRSVPL | 221 | Q8IWB1 | |
| AASPAHWPRESLVLY | 36 | Q96MZ0 | |
| RRSLSPATWDCFHPG | 716 | Q9Y5F9 | |
| HSWASRLFAPNVLPG | 171 | Q96T59 | |
| RLHWPTSLPSGDAFS | 346 | Q9Y5P4 | |
| WAVQALPGLHFTPGR | 206 | P30203 | |
| SFHSAWLTVLPAPGR | 351 | P21802 | |
| LSISGWFHGPSLTRP | 231 | Q8N543 | |
| PLREHATRSPWASDF | 1741 | P78559 | |
| GDWRDPSPRLVLHFG | 156 | Q969S2 | |
| PLRRASLSLGSGFWH | 161 | Q14703 | |
| WKAQHPLLRSLFPEG | 536 | Q9UBC5 | |
| HSFQSRLPLPEPWRG | 311 | Q9HB07 | |
| PFTTDWLGTSPLHLA | 31 | Q06547 | |
| LHLISSFWPSLPSGV | 326 | P08254 | |
| PHTWLGRVLAAGFAL | 291 | P56696 | |
| FRGLPASFHCWLELP | 711 | Q9ULL4 | |
| NHYRFSLSWPRLLPT | 106 | Q6UWM7 | |
| LPAWRTLSVSEHAPG | 821 | P27815 | |
| PGDALFDLLRTWPHF | 531 | Q96PD5 | |
| PVDSTLGFLPWHIRL | 246 | Q96E22 | |
| WPAPLFGLLFLLSSH | 196 | Q96N66 | |
| TGWVGRFRPSEPHFT | 351 | P27487 | |
| FYRWLRSPSSLLHDP | 1821 | Q07864 | |
| PDEDLASFHWSLLGP | 246 | Q9NZB2 | |
| GLPPTWRDFRTLEAF | 291 | Q6P2C8 | |
| WLRNSLRPSPSFTHF | 76 | P23219 | |
| ITGLLFPTSDFWHPV | 551 | P78316 | |
| APNGRNPSFLISSWH | 1486 | Q2PPJ7 | |
| SLLPLPEWFFSTIRH | 166 | Q8TDV0 | |
| VILFTLLAGSPPFWH | 221 | P15735 | |
| LLAGSPPFWHRRQIL | 226 | P15735 | |
| HGAWRLPVSIPLFGR | 256 | Q8TB68 | |
| IWSFSHARRLGPGLE | 196 | Q0D2I5 | |
| GGSPWLHIIIAFPTS | 56 | E5RHQ5 | |
| RGLEAPPRGWSVSLH | 681 | Q96JP2 | |
| QSLFLGAPFPSWLHG | 96 | Q9H8P0 | |
| GAPFPSWLHGLLRIL | 101 | Q9H8P0 | |
| FLHPDAWVRGRSPSD | 231 | Q9UF02 | |
| PLSFHRKCSLWAPGR | 36 | O95838 | |
| PVLFVVPWGFARAHL | 311 | O95838 | |
| LPEPTFWHGSVSIFR | 546 | Q9UJP4 | |
| ERWHTLTSELPPAAG | 381 | Q14183 | |
| FLLHPERWLGTRGDP | 91 | Q5SZD1 | |
| HSAAPRLFPLAWTVL | 181 | P20827 | |
| LGEPFFTTSLLPWHN | 476 | Q9NVM4 | |
| LLTPWHLVFAARGPA | 266 | O43323 | |
| LPNRPHWFLLFGATE | 256 | Q96S94 | |
| LDTLAAPYLAGHWPR | 221 | Q6P1L5 | |
| RVPSHFSRLPLGGWA | 796 | Q7Z3C6 | |
| RWVTPAGRPDFDHLL | 116 | Q9H9V9 | |
| HLRDSGLWFPVDPGA | 146 | Q86WU2 | |
| TFPGITPHLATLSWF | 126 | Q58HT5 | |
| SLPHLAGREGWAFLP | 81 | B7Z1M9 | |
| RPDATVGWHPINLFL | 176 | A0A1W2PPF3 | |
| QHPFFTGLDWTGLLR | 781 | Q6P0Q8 | |
| AWLLHPALPSTFRSV | 6 | P14735 | |
| PIWGLATHPSRDFFL | 1696 | Q05BV3 | |
| APEPVLSGAHTWRSL | 86 | Q6UWU4 | |
| FVPNDRPTWHILAGL | 21 | Q15125 | |
| HTWAPTPQGLLLLDF | 271 | Q86YV9 | |
| HPGFLTAWPADRTAD | 351 | Q7Z7M8 | |
| IPGLGRHSSTFVPWE | 716 | Q6P3S1 | |
| FSWPGTHRATPAFLV | 191 | Q1ZYL8 | |
| GHRPAFPNSSWLPFH | 26 | A0A1B0GVH4 | |
| PPSRETVGHLWFVLF | 191 | A0A1B0GVH4 | |
| VLARPGSSLFSWHPV | 36 | O14569 | |
| HLRSWEALLQSPFFP | 26 | O95992 | |
| NSELFLRHVPGWLRP | 231 | Q6UX07 | |
| HSPLDRFFSSPLWHP | 121 | Q14154 | |
| AFHIAAPLPVTATRW | 291 | P98161 | |
| FFATSDSQPPRLHWL | 406 | Q6J4K2 | |
| DSQPPRLHWLFAFLG | 411 | Q6J4K2 | |
| AHRSPAVLPLGAWVL | 131 | Q9Y4I5 | |
| PPLSTWDFEHLLLTG | 111 | Q6P0A1 | |
| HISPVLAWGFLGPRN | 536 | Q8NAN2 | |
| RSWRAGSYLPLPHGS | 326 | Q96CW9 | |
| LASRHWQGLPSPVDA | 331 | P24347 | |
| PFTTDWLGTSPLHLA | 31 | Q8TAK5 | |
| FWPAPSLSLGVPLHR | 321 | Q96GQ5 | |
| FVGLWISVPFALSHP | 196 | Q9GZV3 | |
| LASFRPPFWGLRHSR | 6 | Q5ST30 | |
| HVRWEAPFRPNGLLT | 2346 | O75445 | |
| PPAPVLHFFLDSRWG | 526 | Q7Z4K8 | |
| IFPHWFPFSRALSGA | 16 | Q8N3R3 | |
| SLLWPGLTFYHAPRT | 241 | Q9H1X1 | |
| LDPDPFVRHTFWTLA | 246 | Q9Y289 | |
| DSWGILFSHPRDFTP | 31 | P30041 | |
| LESLGAVFPHEPWLR | 81 | Q9BRB3 | |
| QSAHPAPTRGALTFW | 46 | Q9NV39 | |
| LVSNSWAHAIFLPRP | 116 | Q9NV39 | |
| LPLGGFQTHPTLLWE | 131 | Q8TCY5 | |
| PFVASSAALRHWPFG | 101 | P31391 | |
| LARASQGLASHLPPW | 1161 | Q9UL54 | |
| TIPPGLFWRFQITIH | 411 | Q9UKZ4 | |
| SHRGPLFIWTISGPD | 146 | Q8IZU2 | |
| LFLSSPAWLPLHGVE | 61 | Q15477 | |
| WVQLDLHFPPGLSFR | 816 | P20701 | |
| HPRTRYSPGWDAKLL | 276 | Q92781 | |
| LSAFPGRHLSGLSWP | 41 | Q96A09 | |
| LVLPRGPDHFSWASP | 396 | Q9GZS9 | |
| GQRVSFFAWHRSPRP | 256 | Q9Y240 | |
| PAPFTPHSRFEVLGW | 361 | Q9P2E5 | |
| VSWFADHPRAPFGLH | 216 | Q86TL0 | |
| SWGFVHPRLLSVPEL | 126 | Q86VR2 | |
| GSHIPGWFRALLPKA | 66 | O00562 | |
| DTSLQPIHPWFLLLG | 181 | Q8TCV5 | |
| PDPTFRGLWSAFHVE | 356 | Q86UP3 | |
| VLRWGDPPFHTAGRL | 926 | Q9BX84 | |
| AARRHPWPTNVLLYG | 11 | Q2QL34 | |
| SALPHAARGWAPFPV | 46 | Q13064 | |
| SVLLWPHQPSGQRSF | 991 | Q9NR96 | |
| PFLTAEPTHLRVGWA | 671 | Q15413 | |
| GSSFIPGEHFWLLLL | 141 | Q9H2V7 | |
| PRSGLPLWAEGLTFF | 171 | Q9BTD3 | |
| WHLREFPLHPVASFS | 406 | P47872 | |
| IGRRSSDPWSNSHFP | 1866 | Q92545 | |
| AHEAPAFLPWHRLFL | 201 | P14679 | |
| PWADGDPRKFISLHR | 2726 | Q6ZS81 | |
| FSRFTLWGLETIPGP | 126 | Q8TDP1 | |
| RFLDAHGAWLPELPS | 441 | Q3KQV9 | |
| RHSPFRWPVLESNIG | 161 | P78562 | |
| LLWTPGPKLFHGSLE | 101 | Q9BRR9 | |
| PFPQTGTWFLALRSL | 146 | A6NDV4 | |
| RSQPEPLSSHSGLWR | 56 | B3SHH9 | |
| ALHLLPAAFSPFIWV | 126 | A1L4Q6 | |
| AAPHLTPFSAWALRH | 936 | Q9BWH6 | |
| RPFWTFRVSHSPLLE | 136 | Q8IYB0 | |
| PAWGPRAHRAYLTLL | 201 | Q9UKP6 | |
| NFLSATHLGGLFPPW | 336 | A1YPR0 | |
| IPPLLVAFRSHGFWL | 36 | Q9H6L2 | |
| PLPVTLALGAFLNHW | 281 | Q969M1 | |
| TGIAWRHPHDPSFLL | 301 | Q96S15 | |
| WFLALRQHGVPLSGP | 131 | Q53EQ6 | |
| RASWAFSHRFPSPLA | 16 | Q6P5S7 | |
| WLRVFSHSSPTGLPK | 36 | Q9Y6J3 | |
| IRRWRSLPGSPEFLH | 451 | Q96S53 | |
| EPVTFAWQHRAPRGL | 176 | P0DP72 | |
| LEFGVPSPAHLRAWT | 1011 | Q9NVE5 | |
| PPWHLGVDSLFRRKA | 416 | Q6BDS2 | |
| DALPLHIAPRWFSSH | 126 | Q8ND25 | |
| LTAHWVSFESPARPR | 746 | O75132 | |
| RGLRTSPVHPNLWAS | 341 | Q6NSI3 | |
| LPQHTPTSRIVLWGF | 196 | Q96S06 | |
| GSGRRIIADTHLFWP | 586 | O75096 |